Arrowhead Pharmaceuticals所有資訊

Arrowhead Pharmaceuticals | 144：擬議出售證券

05/02 14:44 (美東)

Arrowhead Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(10.01%)

04/10 14:08 (美東)

Arrowhead Pharmaceuticals | 4：持股變動聲明-高管 Hamilton James C

04/03 18:09 (美東)

Arrowhead Pharmaceuticals | 144：擬議出售證券

04/01 16:33 (美東)

Arrowhead Pharmaceuticals | 4：持股變動聲明-董事 Lu Hongbo

03/20 19:08 (美東)

Arrowhead Pharmaceuticals | 8-K：重大事件

03/19 16:42 (美東)

Arrowhead Pharmaceuticals | 3：首次持股聲明-董事 Lu Hongbo

03/18 19:01 (美東)

Arrowhead Pharmaceuticals | 8-K/A：重大事件(修正)

03/18 15:37 (美東)

Arrowhead Pharmaceuticals | 4：持股變動聲明-高管 Myszkowski Kenneth Allen

03/08 17:57 (美東)

Arrowhead Pharmaceuticals | 144：擬議出售證券

03/06 17:35 (美東)

Arrowhead Pharmaceuticals | S-8：員工福利計劃證券登記

02/28 22:29 (美東)

Arrowhead Pharmaceuticals | DEFA14A：其他

02/27 17:15 (美東)

Arrowhead Pharmaceuticals | 8-K：重大事件

02/22 14:40 (美東)

Arrowhead Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(9.93%)

02/13 17:00 (美東)

Arrowhead Pharmaceuticals | 10-Q：季度報表

02/06 16:19 (美東)

Arrowhead Pharmaceuticals | 8-K：Arrowhead Pharmicals公佈2024財年第一季度業績

02/06 16:08 (美東)

Arrowhead Pharmaceuticals | 4：持股變動聲明-高管 Anzalone Christopher Richard

02/02 17:27 (美東)

Arrowhead Pharmaceuticals | 144：擬議出售證券

01/31 17:03 (美東)

Arrowhead Pharmaceuticals | ARS：年度報告

01/29 14:48 (美東)

Arrowhead Pharmaceuticals | DEF 14A：股東委託書決議

01/26 17:32 (美東)